PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Symptom | C0020541|portal hypertension |
| Sentences | 72 |
| PubMedID- 23326153 | The transjugular intrahepatic portosystemic shunt (tips) is an acceptable procedure that has proven benefits in the treatment of patients who have complications from portal hypertension due to liver cirrhosis. |
| PubMedID- 21802316 | Purpose: to develop a clinically relevant porcine model of liver cirrhosis with portal hypertension by means of hepatic transarterial embolization. |
| PubMedID- 24960036 | Objective: to investigate the effects and technical points of laparoscopic splenectomy and esophagogastric devascularization (ls+ed) for portal hypertension (ph) due to liver cirrhosis. |
| PubMedID- 22900219 | The patient underwent a computed tomography (ct) of the abdomen which showed liver cirrhosis with signs of portal hypertension, a tortuous and ectasic splenic artery with some widely dilated sections (max 24 mm caliber), and massive aneurysmal dilation in the middle tract (90 mm of maximum diameter) with partly calcified walls, inducing a cranial displacement of the tail and the body of the pancreas (figure 1). |
| PubMedID- 23743385 | However, an increase in splenic blood flow may play a role in the development of saa in patients with portal hypertension due to liver cirrhosis or transplantation. |
| PubMedID- 21577041 | The main cause of gastroesophageal variceal bleeding (gevb) is portal hypertension (ph) due to liver cirrhosis. |
| PubMedID- 22009385 | Background: portal hypertension associated with liver cirrhosis increases the risk of postoperative complications after liver resection for hepatocellular carcinoma (hcc). |
| PubMedID- 24673975 | Thrombocytopenia: in time, liver cirrhosis leads to portal hypertension. |
| PubMedID- 25336484 | Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 21994879 | In our two cases, the patients' risk factors included portal hypertension due to liver cirrhosis, and previous surgery. |
| PubMedID- 26302944 | Additionally, portal hypertensive enteropathy (phe) associated with portal hypertension in patients with liver cirrhosis has been reported to be a major cause of gastrointestinal bleeding . |
| PubMedID- 24574834 | Variceal bleeding is one of the most fatal complications of portal hypertension in patients with liver cirrhosis . |
| PubMedID- 26357501 | The presence of ascites is one of complications of portal hypertension due to advanced liver cirrhosis. |
| PubMedID- 23248978 | Aim: to investigate the feasibility, effectiveness, and safety of a combination therapy of laparoscopic splenectomy (ls) with pericardial devascularization (pd) (laparoscopic hassab's procedure) with or without limited portacaval shunt (lps) for patients with portal hypertension due to liver cirrhosis. |
| PubMedID- 25812120 | In some patients liver fibrosis leads to liver cirrhosis with portal hypertension, hepatocellular dysfunction and increased risk of hepatocellular carcinoma . |
| PubMedID- 23403613 | The only inclusion criterion was the presence of clinical portal hypertension with intrinsic liver cirrhosis. |
| PubMedID- 22591184 | Aim: to study soluble plasma (s) cd163, a specific marker of activated macrophages, as a biomarker for portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25888771 | A 56-year-old chinese man with a history of portal hypertension due to hbv-related liver cirrhosis and known former recurrent esophageal varices bleeding status post sengstaken-blakemore tube tamponade was referred to our hospital for liver transplantation evaluation because of persistent esophagogastric varices bleeding with hypovolemic shock, even after medical and endoscopic therapies in a local hospital. |
| PubMedID- 24963938 | Patients with hcc are predisposed to upper gi haemorrhage as they commonly have portal hypertension either due to underlying liver cirrhosis or due to portal vein involvement by tumour thrombus. |
| PubMedID- 22114590 | We have a long-lasting interest in applying endoscopic ultrasound for the study of features of portal hypertension in patients with liver cirrhosis . |
| PubMedID- 23547461 | The protective effect of n-acetylcysteine magnesium against liver cirrhosis with portal hypertension in rat. |
| PubMedID- 24775062 | Pathology such as myeloproliferative disorder, liver cirrhosis with portal hypertension, deficiency of natural anticoagulant proteins such as protein c or antithrombin iii as well as hepatocellular carcinoma also could contribute to pvt. |
| PubMedID- 25256370 | Background: decreased antithrombin iii (atiii) activity and large splenic vein diameter (svd) are risk factors for portal vein thrombosis (pvt) after splenectomy in liver cirrhosis with portal hypertension. |
| PubMedID- 26159275 | This might explain the pathophysiologic correlation between microbial infections and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 22916658 | portal hypertension and varices in patients with liver cirrhosis. |
| PubMedID- 24974920 | So, the current study was conducted to evaluate cardiac systolic and diastolic functions in liver cirrhosis patients with portal hypertension by conventional doppler echocardiography and tdi. |
| PubMedID- 25499848 | Portal hypertensive gastropathy (ghp) is a complication of portal hypertension usually associated with liver cirrhosis. |
| PubMedID- 26516439 | The american association for the study of liver diseases (aasld) and the european association for the study of the liver (easl) have established guidelines that indicate that liver cirrhosis with portal hypertension is a relative contraindication for hepatic resection because of the high risk liver failure after the operation (14–17). |
| PubMedID- 20534306 | The transjugular intrahepatic portosystemic shunt (tips) is an acceptable procedure that has proven benefits in the treatment of patients who have complications from portal hypertension due to liver cirrhosis. |
| PubMedID- 20698946 | Introduction: varices of the colon are a rare cause of lower gastrointestinal bleeding, usually associated with portal hypertension due to liver cirrhosis or other causes of portal venous obstruction. |
| PubMedID- 23787475 | In consideration of the decompression effect of sn , sn has been identified as a potential safe and effective absorption enhancer of oct for portal hypertension due to liver cirrhosis. |
| PubMedID- 25933224 | liver cirrhosis with portal hypertension is characterized by systemic and splanchnic vasodilatory substances release, especially nitric oxide (no) and prostacyclin 3, which lead to hyperdynamic circulatory status, and further increased mesenteric blood flow and portal inflow. |
| PubMedID- 23855493 | Impaired endothelial function is a major cause of portal hypertension in liver cirrhosis. |
| PubMedID- 24820919 | Case background: ascites appears mainly as a consequence of portal hypertension in patients with liver cirrhosis, or can be caused by several other causes, such us congestive heart failure, peritoneal malignancy, or tuberculosis. |
| PubMedID- 26370856 | Hypothyroidism enhanced portal hypertension in a patient with alcoholic liver cirrhosis, resulting in the development of ascites. |
| PubMedID- 25374728 | Variceal bleeding is the major complication of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25656015 | Case report : bleeding from ileal conduit in a patient with portal hypertension due to liver cirrhosis type c. |
| PubMedID- 25374673 | Future therapy of portal hypertension in liver cirrhosis - a guess. |
| PubMedID- 23984413 | Spleen stiffness, but not liver stiffness, was positively correlated with the presence of ascites as a representative marker of portal hypertension in patients with liver cirrhosis and the spleen stiffness did not correlate with the presence of esophageal varices in chronic hepatitis c patients. |
| PubMedID- 24812632 | Therefore, intervention of this signaling pathway (particularly inhibition of tgf-β1 levels) may be an important target for the prevention and treatment of portal hypertension due to liver cirrhosis. |
| PubMedID- 26152281 | 3a), which showed that igf-1 was a negative regulating factor in portal hypertension of liver cirrhosis. |
| PubMedID- 20652243 | Four patients underwent splenectomy because of liver cirrhosis with portal hypertension and gastroesophageal variceal bleeding. |
| PubMedID- 24331694 | Non-invasive assessment of portal hypertension in patients with liver cirrhosis using fibroscan transient elastography. |
| PubMedID- 21606920 | The experimental study of liver cirrhosis with portal hypertension syndrome, modeled in 38 dogs, has been performed. |
| PubMedID- 26091449 | Esophageal varix is one of the serious complications of liver cirrhosis resulting from portal hypertension.1 given the high prevalence of varices and the significant mortality rate associated with variceal hemorrhage, early diagnosis of clinically significant portal hypertension (≥10 mm hg) and varices is of paramount importance in the management of compensated cirrhosis and in the prevention of liver-related morbidity and mortality. |
| PubMedID- 25038804 | Estimation of the severity of portal hypertension in patients with liver cirrhosis is another major use of liver stiffness measurements. |
| PubMedID- 21506350 | An analysis of 115 liver cirrhosis patients with portal hypertension was made to find out which of them had variceal bleeding and high risk of its development. |
| PubMedID- 24949616 | Partial splenic embolization is an effective interventional procedure performed in liver cirrhosis complicated with portal hypertension to improve the low platelet count. |
| PubMedID- 21701671 | She was a known case of cryptogenic liver cirrhosis with portal hypertension. |
| PubMedID- 25892988 | This study aimed to further investigate portal venous remodeling in the pathogenesis of liver cirrhosis with portal hypertension, thereby guiding its prevention and treatment. |
Page: 1 2